Drug Profile


Alternative Names: capsavanil; DA 5018; KR 25018

Latest Information Update: 08 Nov 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Korea Research Institute of Chemical Technology
  • Developer Dong-A Pharmaceutical
  • Class Non-opioid analgesics
  • Mechanism of Action TRPV cation channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Diabetic neuropathies; Neuralgia; Pain; Pruritus

Most Recent Events

  • 30 Jan 2001 Phase-II clinical trials for Pain in South Korea (Unknown route)
  • 23 Mar 2000 Preclinical development for Pruritus in South Korea (Unknown route)
  • 23 Mar 2000 A study has been added to the Skin disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top